U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07788131) titled 'Inflammatory Biomarkers and Disease Activity in Inflammatory Bowel Disease' on Aug. 22.
Brief Summary: This study aims to evaluate the diagnostic accuracy and clinical utility of routine blood-derived inflammatory biomarker ratios in assessing disease activity among adult patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.
Endoscopy is the standard method for evaluating mucosal inflammation in IBD, but it is invasive, costly, and inconvenient for frequent disease monitoring. Non-invasive, inexpensive laboratory markers derived from standard routine blood tests, specifically the C-reacti...